Gene · 5692
Papers807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A multi-region transcriptomic framework reveals global and region-specific ubiquitin-proteasome system biomarkers in Alzheimer's disease. | Funct Integr Genomics | 2026 | 42809130 | PubTator, text mining | PubMed |
| SADS-CoV Nsp1 hijacks proteasomal subunits to degrade IRF1. | Vet Microbiol | 2026 | 42721780 | PubTator, text mining | PubMed |
| Machine learning-driven QSAR modeling combined with single cell transcriptomics identifies novel drug targets for lung cancer. | J Transl Med | 2026 | 42321836 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Mediated Nucleolin Transfer in Glioblastoma: A Targetable Axis Driving Blood-Tumour Barrier Formation. | J Extracell Vesicles | 2026 | 41926335 | PubTator, text mining | PubMed |
| Sarcomatoid Renal Cell Carcinoma: Biological Features and Therapeutic Implications-A Narrative Review. | Curr Urol Rep | 2026 | 41792526 | PubTator, text mining | PubMed |
| Optimization of potential targets for antidepressant Chinese medicines: AI and multi-omics methods. | Chin Med | 2026 | 41668206 | PubTator, text mining | PubMed |
| Reduced Proteasome Degradation of HSF-1 Shifts Protein Stress Management With Age in Caenorhabditis elegans. | Aging Cell | 2026 | 41612742 | PubTator, text mining | PubMed |
| Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity. | Clin Transl Med | 2025 | 41017066 | PubTator, text mining | PubMed |
| Mechanistic insights into aristolochic acid-induced hepatocellular carcinoma: a multi-dimensional analysis integrating network toxicology, machine learning, and molecular dynamics simulation. | Toxicon | 2025 | 40921337 | PubTator, text mining | PubMed |
| Predictive value of MHC-related genes in cervical cancer: implications for immunotherapy and prognostic nomogram development. | Discov Oncol | 2025 | 40888998 | PubTator, text mining | PubMed |
| Regulation of antiviral and antimicrobial innate immunity and immune evasion. | Cell Mol Life Sci | 2025 | 40879755 | PubTator, text mining | PubMed |
| PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinoma. | Discov Oncol | 2025 | 40856889 | PubTator, text mining | PubMed |
| The prevalence and clinical correlates of severe anxiety symptoms in first-episode drug-naïve schizophrenia: a Chinese population study. | BMC Psychiatry | 2025 | 40739636 | PubTator, text mining | PubMed |
| Exploration of genes related to the development of cancer of unknown primary. | Oncol Rep | 2025 | 40314076 | PubTator, text mining | PubMed |
| S146 and M148 within the mature chain domain of PSMB4 are crucial for degrading PRRSV nsp1α. | Cell Mol Life Sci | 2025 | 40192860 | PubTator, text mining | PubMed |
| PSMB4: a potential biomarker and therapeutic target for depression, perspective from integration analysis of depression GWAS data and human plasma proteome. | Transl Psychiatry | 2025 | 39979251 | PubTator, text mining | PubMed |
| NEK4: prediction of available drug targets and common genetic linkages in bipolar disorder and major depressive disorder. | Front Psychiatry | 2025 | 39950180 | PubTator, text mining | PubMed |
| Traversing the drug discovery landscape using native mass spectrometry. | Curr Opin Struct Biol | 2025 | 39893771 | PubTator, text mining | PubMed |
| Genomics-driven integrative analysis highlights immune-related plasma proteins for psychiatric disorders. | J Affect Disord | 2025 | 39491680 | PubTator, text mining | PubMed |
| Bioinformatics to analyze the differentially expressed genes in different degrees of Alzheimer's disease and their roles in progress of the disease. | J Appl Genet | 2025 | 38315405 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5692/papers